With 20 years of expertise in regenerative tissue engineering, Helios Cardio applies the most advanced regenerative tissue scaffold technology to cardiac tissue repair. 

Combining market-leading mechanical properties, exceptional tissue regeneration characteristics, and proven safety through clinical use in more than 500,000 patients, CardiaMend™ represents a new dawn in cardiac tissue engineering.

CardiaMend™ provides not only mechanical support to cardiac structures, but also the optimal environment for patients' own tissue to grow into and regenerate.  This truly regenerative material opens up new avenues in cardiac care. Helios Cardio is also participating in cutting edge research by combining the mechanotransductive properties of CardiaMend™ with stem cells to provide transformative regenerative strategies for patients suffering from heart failure.

Helios Cardio

Org chart

Teams

Offices